A synbiotic composition and its application

By using bifidobacterium or Lactobacillus in synbiotic composition and glucose or isomaltose, the vitamin B7 yield of probiotics during fermentation is improved, the problem of insufficient yield in the prior art is solved, and efficient Fermentation cultures are used in food and pharmaceutical applications.

CN117898433BActive Publication Date: 2024-11-15GUANGDONG YANTANG DAIRY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410049024.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-01-12
Publication Date
2024-11-15
Estimated Expiration
2044-01-12

AI Technical Summary

Technical Problem

The prior art lacks effective methods to improve the production efficiency of probiotics synthesize vitamin B7 during fermentation, resulting in insufficient production of vitamin B7 and unable to meet nutritional needs.

Method used

Using synbiotic compositions, including the combination of bifidobacterium or Lactobacillus and glucose or isomaltose, the probiotics synthesize vitamin B7 during the fermentation process through specific inoculation and culture conditions, and fermentation containing vitamin B7 is prepared. culture.

Benefits of technology

It significantly improves the vitamin B7 production of probiotics during fermentation, provides applications in food and medicine, and has potential effects on anti-inflammatory and prevent obesity and diabetes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004662207240000051
    Figure BDA0004662207240000051
  • Figure BDA0004662207240000061
    Figure BDA0004662207240000061
  • Figure BDA0004662207240000201
    Figure BDA0004662207240000201
Patent Text Reader

Abstract

The present invention discloses a synbiotic composition and its application, wherein the synbiotic composition comprises: bifidobacterium and / or lactobacillus, and glucose or prebiotics; the prebiotics comprise oligomalto-oligosaccharide; the bifidobacterium or lactobacillus is inoculated in a fermentation substrate in the form of seed liquid, the inoculation amount of the bifidobacterium or lactobacillus is 1% to 5%, and the inoculation concentration is 1×10 7 cfu / mL~1×10 11 cfu / mL; the final concentration of the prebiotic is 10g / L to 50g / L. The synbiotic composition provided by the present invention can increase the yield of vitamin B7 synthesized by probiotic fermentation.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of microbial cultivation, and in particular relates to a synbiotic composition and application thereof. Background Art

[0002] Vitamin B7, also known as biotin, is abundant in eggs, fish, soybeans and nuts. The World Health Organization (WHO) / Food and Agriculture Organization (FAO) recommends that adults take 30 μg of vitamin B7 per day. Vitamin B7 plays an important role in gene regulation and cell signal transduction. It also participates in the metabolism of fatty acids, carbohydrates and amino acids. Dietary supplementation of vitamin B7 can accelerate the body's metabolism to reduce the risk of obesity and diabetes. Vitamin B7 can inhibit the expression of nuclear factor NF-κB related genes through histone binding mechanism, thereby inhibiting inflammation.

[0003] The results of metagenomic studies show that actinomycetes such as bifidobacteria, such as Ruminococcus and Lactobacillus, lack the genes necessary to synthesize vitamin B7 and need to obtain vitamin B7 from the environment to meet nutritional needs. Studies have shown that a decrease in the pH level in the intestine will increase the transport and absorption of vitamin B7, and bifidobacteria, lactobacillus, enterococci and streptococci can produce metabolites such as lactic acid in the intestine, which reduces the pH value of the intestine and helps the absorption of vitamin B7. At present, there are few studies on microorganisms that synthesize vitamin B7, and there are no reports on the effects of prebiotics on the synthesis of vitamin B7 by probiotics. At present, there is an urgent need to develop new synbiotic compositions to improve the production efficiency of vitamin B7 produced by probiotic fermentation. Summary of the invention

[0004] The present invention aims to solve at least one of the technical problems existing in the above-mentioned prior art. To this end, the present invention provides a synbiotic composition that can increase the yield of vitamin B7 synthesized by probiotic fermentation.

[0005] The invention also provides a method for promoting probiotics to ferment and synthesize vitamin B7.

[0006] The present invention also provides a fermentation culture prepared by the method.

[0007] The invention also provides a food or a medicine.

[0008] The present invention also provides the application of the synbiotic composition.

[0009] The present invention also provides the application of the fermentation culture.

[0010] According to a first aspect of the present invention, a synbiotic composition is provided, comprising:

[0011] (1) Bifidobacterium and / or Lactobacillus, and

[0012] (2) glucose or prebiotics;

[0013] The prebiotics include isomaltooligosaccharide;

[0014] The bifidobacterium or lactobacillus is inoculated in the fermentation substrate in the form of seed liquid, and the inoculation amount of the bifidobacterium or lactobacillus is 1% to 5% and the inoculation concentration is 1×10 7 cfu / mL~1×10 11 cfu / mL;

[0015] The final concentration of the prebiotics is 10 g / L to 50 g / L.

[0016] In some embodiments of the present invention, the inoculation amount of the bifidobacterium or lactobacillus is 1%.

[0017] In some embodiments of the present invention, the inoculation concentration of the bifidobacterium or lactobacillus is 1×10 8 cfu / mL~1×10 10 cfu / mL.

[0018] In some preferred embodiments of the present invention, the inoculation concentration of the bifidobacterium or lactobacillus is 1×10 9 cfu / mL.

[0019] In some embodiments of the present invention, the final concentration of glucose or prebiotics is 15 g / L to 30 g / L.

[0020] In some preferred embodiments of the present invention, the final concentration of glucose or prebiotics is 20 g / L.

[0021] In some embodiments of the present invention, the isomaltooligosaccharide complies with the provisions of the national standard GB / T20885-2017.

[0022] In some embodiments of the present invention, the bifidobacterium comprises at least one of Bifidobacterium animalis subsp. lactis, Bifidobacterium animalis subsp. lactis and Bifidobacterium bifidum.

[0023] In some preferred embodiments of the present invention, the animal Bifidobacterium lactis subspecies includes at least one of animal Bifidobacterium lactis subspecies BB-12, animal Bifidobacterium lactis subspecies BL-04, animal Bifidobacterium lactis subspecies B420, animal Bifidobacterium lactis subspecies HN019, animal Bifidobacterium lactis subspecies Y6 and animal Bifidobacterium lactis subspecies CECT8145.

[0024] In some preferred embodiments of the present invention, the Bifidobacterium longum subsp. longum includes Bifidobacterium longum subsp. longum W68.

[0025] In some preferred embodiments of the present invention, the Bifidobacterium bifidum includes Bifidobacterium bifidum Y22.

[0026] In some embodiments of the present invention, the lactobacillus includes at least one of Lactobacillus plantarum, Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus paracasei, Lactobacillus casei, Lactobacillus gasseri and Lactobacillus reuteri.

[0027] In some preferred embodiments of the present invention, the Lactobacillus plantarum includes at least one of Lactobacillus plantarum FEED8, Lactobacillus plantarum LP45 and Lactobacillus plantarum CN2018.

[0028] In some preferred embodiments of the present invention, the Lactobacillus acidophilus includes at least one of Lactobacillus acidophilus K43, Lactobacillus acidophilus NCFM and Lactobacillus acidophilus LA-5.

[0029] In some preferred embodiments of the present invention, the Lactobacillus rhamnosus includes at least one of Lactobacillus rhamnosus YGG and Lactobacillus rhamnosus HN001.

[0030] In some preferred embodiments of the present invention, the Lactobacillus paracasei includes at least one of Lactobacillus paracasei K9 and Lactobacillus paracasei Lpc-37.

[0031] In some preferred embodiments of the present invention, the Lactobacillus casei includes Lactobacillus casei K35.

[0032] In some preferred embodiments of the present invention, the Lactobacillus gasseri includes Lactobacillus gasseri BDUP.

[0033] In some preferred embodiments of the present invention, the Lactobacillus reuteri includes Lactobacillus reuteri K07.

[0034] In some embodiments of the invention, the synbiotic composition is Bifidobacterium and glucose.

[0035] In some preferred embodiments of the present invention, the synbiotic composition is glucose and Bifidobacterium longum subsp. longum W68.

[0036] In some embodiments of the present invention, the synbiotic composition is Lactobacillus and isomaltooligosaccharide.

[0037] In some preferred embodiments of the present invention, the synbiotic composition is isomaltooligosaccharide and Lactobacillus acidophilus LA-5.

[0038] According to the second aspect of the present invention, a method for promoting probiotic fermentation to synthesize microorganism B7 is proposed, the method comprising the following steps: adding the synbiotic composition described in the first aspect of the present invention into a culture medium, culturing at 30°C to 40°C for 18 to 30 hours, and obtaining a fermentation culture containing vitamin B7.

[0039] In some embodiments of the present invention, the culturing time is 20 to 28 hours.

[0040] In some preferred embodiments of the present invention, the culturing time is 24 hours.

[0041] In some embodiments of the present invention, the culture medium is a carbon source-free MRS medium supplemented with 0.03% to 0.07% cysteine ​​hydrochloride.

[0042] In some preferred embodiments of the present invention, the culture medium is a carbon-free MRS culture medium supplemented with 0.05% cysteine ​​hydrochloride. In some preferred embodiments of the present invention, the carbon-free MRS culture medium comprises beef extract powder, tryptone, yeast extract powder, dipotassium hydrogen phosphate, triammonium citrate, magnesium sulfate heptahydrate, manganese sulfate tetrahydrate, sodium acetate, and Tween-80.

[0043] In some more preferred embodiments of the present invention, the carbon source-free MRS medium includes 8-12 g / L beef extract powder, 8-12 g / L tryptone, 4-6 g / L yeast extract powder, 1-3 g / L dipotassium hydrogen phosphate, 1-3 g / L triammonium citrate, 0.4-0.6 g / L magnesium sulfate heptahydrate, 0.2-0.3 g / L manganese sulfate tetrahydrate, 4-6 g / L sodium acetate, and 0.05 v / v% to 0.2 v / v% Tween-80.

[0044] According to a third aspect of the present invention, a probiotic fermentation culture is provided, wherein the fermentation culture is prepared using the synbiotic composition according to the first aspect of the present invention and / or the method according to the second aspect of the present invention.

[0045] In some embodiments of the present invention, the fermentation culture contains 4-25 μg / L vitamin B7.

[0046] In some preferred embodiments of the present invention, the fermentation culture contains 10-20 μg / L vitamin B7.

[0047] In some embodiments of the present invention, the synbiotic composition is glucose and Bifidobacterium longum subsp. longum W68, and the fermentation culture contains 19.78 μg / L vitamin B7.

[0048] In some embodiments of the present invention, the synbiotic composition is isomaltooligosaccharide and Lactobacillus acidophilus LA-5, and the fermentation culture contains 10.67 μg / L vitamin B7.

[0049] According to a fourth aspect of the present invention, a food or a medicine is provided, wherein the food or the medicine comprises the synbiotic composition according to the first aspect of the present invention and / or the fermentation culture according to the third aspect of the present invention.

[0050] In some embodiments of the present invention, the food comprises at least one of dairy products, cereal products, bean products, condiments, ice products and beverages.

[0051] In some preferred embodiments of the present invention, the dairy product is selected from at least one of sterilized milk, sterilized milk, reconstituted milk, yogurt, yogurt, milk powder, formula milk powder, condensed milk, cheese, casein, whey powder and milk fat.

[0052] According to a fifth aspect of the present invention, there is provided a use of the synbiotic composition according to the first aspect of the present invention in promoting probiotic fermentation to synthesize vitamin B7.

[0053] According to a sixth aspect of the present invention, there is provided a use of the synbiotic composition according to the first aspect of the present invention and / or the fermentation culture according to the third aspect of the present invention in any one of (1) to (4):

[0054] (1) Preparation of food;

[0055] (2) Preparation of anti-inflammatory drugs;

[0056] (3) Preparation of drugs for preventing or treating obesity;

[0057] (4) Preparation of drugs for preventing or treating diabetes. DETAILED DESCRIPTION

[0058] The following will be combined with the embodiments to clearly and completely describe the concept of the present invention and the technical effects produced, so as to fully understand the purpose, characteristics and effects of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, other embodiments obtained by those skilled in the art without creative work are all within the scope of protection of the present invention.

[0059] Example 1

[0060] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subsp. lactis BB-12 and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are as follows:

[0061] 1) In a clean bench, a small amount of freeze-dried bacterial powder of animal Bifidobacterium lactis subsp. BB-12 was inoculated into MRSc liquid culture medium, and cultured in a 37° C. incubator for 24 h. The cultured bacterial solution was mixed with an equal volume of 50% glycerol (pure glycerol and physiological saline were mixed in equal volumes), and then stored at -80° C. The specific information of the freeze-dried bacterial powder used in the embodiment of the present invention is shown in Table 1;

[0062] 2) Streak the frozen strain in step 1) on a MRSc plate, culture at 37°C for 48 hours, pick a single colony and culture in MRSc liquid culture medium for 24 hours;

[0063] 3) The bacterial solution obtained by culture in step 2) was transferred to a fresh MRSc liquid culture medium at a 1% inoculum amount, and after culturing at 37° C. for 24 h, it was transferred to a MRSc culture medium with glucose as the carbon source (the amount of glucose added was 20 g / L) (the formula of the MRSc culture medium includes: weighing 10 g beef extract powder, 10 g tryptone, 5 g yeast extract powder, 2 g dipotassium hydrogen phosphate, 2 g triammonium citrate, 0.5 g magnesium sulfate heptahydrate, 0.25 g manganese sulfate tetrahydrate, 5 g sodium acetate, 1 mL Tween-80 and 0.5 g cysteine ​​hydrochloride, dissolved in 980 mL distilled water, fixed to 1 L, sterilized at 121° C. for 15 min, and cooled), and cultured at 37° C. for 24 h;

[0064] 4) Collect the bacterial solution obtained by culture in step 3), centrifuge it at 4°C and 8000 rpm for 10 min, take the supernatant, filter it with a sterile 0.22 μm filter membrane, divide it into sterile cryopreservation tubes, and freeze it at -80°C for later use.

[0065] Table 1 Bacterial species name, number, purchase source and corresponding examples

[0066]

[0067]

[0068] Example 2

[0069] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subsp. lactis BB-12 and oligofructose; this embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0070] Example 3

[0071] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subsp. lactis BB-12 and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0072] Example 4

[0073] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subsp. lactis BB-12 and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0074] Example 5

[0075] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subsp. lactis BL-04 and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0076] Example 6

[0077] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subsp. lactis BL-04 and oligofructose; this embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0078] Example 7

[0079] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subspecies lactis BL-04 and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0080] Example 8

[0081] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subsp. lactis BL-04 and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0082] Example 9

[0083] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subsp. lactis B420 and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0084] Example 10

[0085] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subsp. lactis B420 and oligofructose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0086] Embodiment 11

[0087] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subsp. lactis B420 and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0088] Example 12

[0089] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subsp. lactis B420 and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0090] Embodiment 13

[0091] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subsp. lactis HN019 and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0092] Embodiment 14

[0093] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subsp. lactis HN019 and oligofructose; this embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0094] Embodiment 15

[0095] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subsp. lactis HN019 and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0096] Example 16

[0097] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subsp. lactis HN019 and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0098] Embodiment 17

[0099] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subspecies lactis Y6 and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0100] Embodiment 18

[0101] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis lactis subspecies Y6 and oligofructose; this embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0102] Embodiment 19

[0103] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis lactis subspecies Y6 and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0104] Embodiment 20

[0105] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis lactis subspecies Y6 and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0106] Embodiment 21

[0107] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subspecies lactis CECT8145 and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0108] Embodiment 22

[0109] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subspecies lactis CECT8145 and oligofructose; this embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0110] Embodiment 23

[0111] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subspecies lactis CECT8145 and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0112] Embodiment 24

[0113] This embodiment provides a synbiotic composition, which includes Bifidobacterium animalis subspecies lactis CECT8145 and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0114] Embodiment 25

[0115] This embodiment provides a synbiotic composition, which includes Bifidobacterium longum subspecies longum W68 and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0116] Embodiment 26

[0117] This embodiment provides a synbiotic composition, which includes Bifidobacterium longum subspecies longum W68 and oligofructose; this embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0118] Embodiment 27

[0119] This embodiment provides a synbiotic composition, which includes Bifidobacterium longum subspecies longum W68 and galacto-oligosaccharide; this embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0120] Embodiment 28

[0121] This embodiment provides a synbiotic composition, which includes Bifidobacterium longum subspecies longum W68 and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0122] Embodiment 29

[0123] This embodiment provides a synbiotic composition, which includes Bifidobacterium bifidum Y22 and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0124] Embodiment 30

[0125] This embodiment provides a synbiotic composition, which includes Bifidobacterium bifidum Y22 and oligofructose; this embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0126] Embodiment 31

[0127] This embodiment provides a synbiotic composition, which includes Bifidobacterium bifidum Y22 and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0128] Embodiment 32

[0129] This embodiment provides a synbiotic composition, which includes Bifidobacterium bifidum Y22 and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0130] Embodiment 33

[0131] This embodiment provides a synbiotic composition, which includes Lactobacillus plantarum FEED8 and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0132] Embodiment 34

[0133] This embodiment provides a synbiotic composition, which includes Lactobacillus plantarum FEED8 and oligofructose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0134] Embodiment 35

[0135] This embodiment provides a synbiotic composition, which includes Lactobacillus plantarum FEED8 and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0136] Embodiment 36

[0137] This embodiment provides a synbiotic composition, which includes Lactobacillus plantarum FEED8 and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0138] Embodiment 37

[0139] This embodiment provides a synbiotic composition, which includes Lactobacillus plantarum LP45 and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0140] Embodiment 38

[0141] This embodiment provides a synbiotic composition, which includes Lactobacillus plantarum LP45 and oligofructose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0142] Embodiment 39

[0143] This embodiment provides a synbiotic composition, which includes Lactobacillus plantarum LP45 and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0144] Embodiment 40

[0145] This embodiment provides a synbiotic composition, which includes Lactobacillus plantarum LP45 and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0146] Embodiment 41

[0147] This embodiment provides a synbiotic composition, which includes Lactobacillus plantarum CN2018 and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0148] Embodiment 42

[0149] This embodiment provides a synbiotic composition, which includes Lactobacillus plantarum CN2018 and oligofructose; this embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0150] Embodiment 43

[0151] This embodiment provides a synbiotic composition, which includes Lactobacillus plantarum CN2018 and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0152] Embodiment 44

[0153] This embodiment provides a synbiotic composition, which includes Lactobacillus plantarum CN2018 and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0154] Embodiment 45

[0155] This embodiment provides a synbiotic composition, which includes Lactobacillus acidophilus K43 and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0156] Embodiment 46

[0157] This embodiment provides a synbiotic composition, which includes Lactobacillus acidophilus K43 and oligofructose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0158] Embodiment 47

[0159] This embodiment provides a synbiotic composition, which includes Lactobacillus acidophilus K43 and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0160] Embodiment 48

[0161] This embodiment provides a synbiotic composition, which includes Lactobacillus acidophilus K43 and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0162] Embodiment 49

[0163] This embodiment provides a synbiotic composition, which includes Lactobacillus acidophilus NCFM and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0164] Embodiment 50

[0165] This embodiment provides a synbiotic composition, which includes Lactobacillus acidophilus NCFM and oligofructose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0166] Embodiment 51

[0167] This embodiment provides a synbiotic composition, which includes Lactobacillus acidophilus NCFM and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0168] Embodiment 52

[0169] This embodiment provides a synbiotic composition, which includes Lactobacillus acidophilus NCFM and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0170] Embodiment 53

[0171] This embodiment provides a synbiotic composition, which includes Lactobacillus acidophilus LA-5 and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0172] Embodiment 54

[0173] This embodiment provides a synbiotic composition, which includes Lactobacillus acidophilus LA-5 and oligofructose; this embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0174] Embodiment 55

[0175] This embodiment provides a synbiotic composition, which includes Lactobacillus acidophilus LA-5 and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0176] Embodiment 56

[0177] This embodiment provides a synbiotic composition, which includes Lactobacillus acidophilus LA-5 and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0178] Embodiment 57

[0179] This embodiment provides a synbiotic composition, which includes Lactobacillus rhamnosus YGG and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0180] Embodiment 58

[0181] This embodiment provides a synbiotic composition, which includes Lactobacillus rhamnosus YGG and oligofructose; this embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0182] Embodiment 59

[0183] This embodiment provides a synbiotic composition, which includes Lactobacillus rhamnosus YGG and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0184] Embodiment 60

[0185] This embodiment provides a synbiotic composition, which includes Lactobacillus rhamnosus YGG and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0186] Embodiment 61

[0187] This embodiment provides a synbiotic composition, which includes Lactobacillus rhamnosus YGG and 2'-fucosyllactose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0188] Embodiment 62

[0189] This embodiment provides a synbiotic composition, which includes Lactobacillus rhamnosus HN001 and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0190] Embodiment 63

[0191] This embodiment provides a synbiotic composition, which includes Lactobacillus rhamnosus HN001 and oligofructose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0192] Embodiment 64

[0193] This embodiment provides a synbiotic composition, which includes Lactobacillus rhamnosus HN001 and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0194] Embodiment 65

[0195] This embodiment provides a synbiotic composition, which includes Lactobacillus rhamnosus HN001 and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0196] Embodiment 66

[0197] This embodiment provides a synbiotic composition, which includes Lactobacillus rhamnosus HN001 and 2'-fucosyllactose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0198] Embodiment 67

[0199] This embodiment provides a synbiotic composition, which includes Lactobacillus paracasei K9 and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0200] Embodiment 68

[0201] This embodiment provides a synbiotic composition, which includes Lactobacillus paracasei K9 and oligofructose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0202] Embodiment 69

[0203] This embodiment provides a synbiotic composition, which includes Lactobacillus paracasei K9 and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0204] Embodiment 70

[0205] This embodiment provides a synbiotic composition, which includes Lactobacillus paracasei K9 and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0206] Embodiment 71

[0207] This embodiment provides a synbiotic composition, which includes Lactobacillus paracasei K9 and 2'-fucosyllactose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0208] Embodiment 72

[0209] This embodiment provides a synbiotic composition, which includes Lactobacillus paracasei Lpc-37 and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0210] Embodiment 73

[0211] This embodiment provides a synbiotic composition, which includes Lactobacillus paracasei Lpc-37 and oligofructose; this embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0212] Embodiment 74

[0213] This embodiment provides a synbiotic composition, which includes Lactobacillus paracasei Lpc-37 and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0214] Embodiment 75

[0215] This embodiment provides a synbiotic composition, which includes Lactobacillus paracasei Lpc-37 and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0216] Embodiment 76

[0217] This embodiment provides a synbiotic composition, which includes Lactobacillus paracasei Lpc-37 and 2'-fucosyllactose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0218] Embodiment 77

[0219] This embodiment provides a synbiotic composition, which includes Lactobacillus casei K35 and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0220] Embodiment 78

[0221] This embodiment provides a synbiotic composition, which includes Lactobacillus casei K35 and oligofructose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0222] Embodiment 79

[0223] This embodiment provides a synbiotic composition, which includes Lactobacillus casei K35 and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0224] Embodiment 80

[0225] This embodiment provides a synbiotic composition, which includes Lactobacillus casei K35 and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0226] Embodiment 81

[0227] This embodiment provides a synbiotic composition, which includes Lactobacillus casei K35 and 2'-fucosyllactose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0228] Embodiment 82

[0229] This embodiment provides a synbiotic composition, which includes Lactobacillus gasseri BDUP and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0230] Embodiment 83

[0231] This embodiment provides a synbiotic composition, which includes Lactobacillus gasseri BDUP and oligofructose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0232] Embodiment 84

[0233] This embodiment provides a synbiotic composition, which includes Lactobacillus gasseri BDUP and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0234] Embodiment 85

[0235] This embodiment provides a synbiotic composition, which includes Lactobacillus gasseri BDUP and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0236] Embodiment 86

[0237] This embodiment provides a synbiotic composition, which includes Lactobacillus reuteri K07 and glucose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0238] Embodiment 87

[0239] This embodiment provides a synbiotic composition, which includes Lactobacillus reuteri K07 and oligofructose. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0240] Embodiment 88

[0241] This embodiment provides a synbiotic composition, which includes Lactobacillus reuteri K07 and galacto-oligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0242] Embodiment 89

[0243] This embodiment provides a synbiotic composition, which includes Lactobacillus reuteri K07 and isomaltooligosaccharide. This embodiment also uses the synbiotic composition to prepare a fermentation culture containing vitamin B7, and the specific steps are the same as those in Example 1.

[0244] Test example

[0245] This test example tests the content of vitamin B7 in the fermentation culture prepared in Examples 1 to 89. The specific test steps and test results are as follows:

[0246] 1) Sample pretreatment: Take out the fermentation culture sample from the -80℃ refrigerator, take 1mL of the sample and freeze-dry it, add 10μL of internal standard and 400μL of pre-cooled methanol / acetonitrile (1:1 mixture, v / v) solution containing 0.3% formic acid, add black ceramic beads, homogenize twice (20s each time), vortex mix for 30s, incubate at 4℃ for 10min to precipitate protein; then centrifuge at 4℃ and 14000rcf for 10min, take 400μL of the supernatant and add 400μL of pre-cooled mass spectrometry grade ultrapure water, vortex mix for 30s, and draw 800μL of the supernatant for solid phase extraction The filtrate was dried and stored at -80°C for testing; the internal standard was a mixture of the following substances: Pyridoxine-(methyl-d3) hydrochloride (Sigma, 809659, 1 mg), Nicotinamide-13C6 solution (Sigma, V-034-1ML, 1ML), Thiamine-(4-methyl-13C-thiazol-5-yl-13C3) hydrochloride (Vitamin B1-13C4)(Sigma,731188,2mg),biotin(3',3',4',4'-d4)(CIL,DLM-9751-PK,1mg),Vitamin B5(di-β-alanine-13C6,15N2)calcium salt(Sigma,705837,5mg), Riboflavin-(dioxopyrimidine-13C4,15N2)(Sigma,705292,1mg), Folic acid-(glutamic acid-13C5)(Sigma,803049,1mg), Nicotinic acid-13C6 solution(Sigma,V-035-1ML,1ML);

[0247] 2) Determination of vitamin B7 content:

[0248] The samples were separated using an Agilent 1290 Infinity LC ultra-high performance liquid chromatography system; the samples were placed in an automatic sampler at 4°C, the column temperature was 45°C, the mobile phase A was 5 mM ammonium formate and 0.3% formic acid aqueous solution (315.28 mg of ammonium formate and 3 mL of formic acid were dissolved in 900 mL of mass spectrometry grade ultrapure water, and after all were dissolved, the volume was fixed to 1 L), the mobile phase B was pure methanol, the flow rate was 300 μL / min, and the injection volume was 5 μL;

[0249] The relevant liquid phase gradient is as follows: 0-2min, liquid B is 0%, 2-3min linearly changes from 0% to 60%; 3-4.5min, liquid B changes linearly from 60% to 100%; 4.5-6min, liquid B changes linearly from 100% to 5%, 6-11min, liquid B is 5%; a QC sample is set for every certain number of experimental samples in the sample queue to detect and evaluate the stability and repeatability of the system; the sample queue is set with a standard mixture of the target substance for the correction of the chromatographic retention time;

[0250] Mass spectrometry analysis was performed using a 5500QTRAP mass spectrometer (AB SCIEX) in positive ion mode, with multiple reaction monitoring (MRM) as the detection method; specific conditions included: ion source temperature: 550°C; nebulizer gas (Gas1): 55 psi; auxiliary gas (Gas2): 55 psi; curtain gas (CUR): 40 psi; electrospray gas pressure (ISVF): +4500 V; after the measurement results were calculated, the data were subjected to inter-group T-test significance analysis; the results are shown in Tables 2 and 3.

[0251] Table 2 Content of vitamin B7 in the fermentation supernatant of bifidobacterium (Examples 1 to 32) (μg / L)

[0252] strain glucose Fructo-oligosaccharides Galacto-oligosaccharides Isomaltooligosaccharide BB12 8.89±0.71 8.38±0.60 9.06±0.27 9.94±0.24 BB04 8.23±0.30 8.74±0.63 8.67±0.35 8.81±0.32 BB420 8.51±0.43 9.23±0.40 8.61±0.31 9.25±0.29 BB019 9.20±0.06 9.41±0.58 9.31±0.63 9.56±1.06 BB6 9.39±0.34 9.89±1.01 9.89±0.20 9.65±0.36 BB8145 7.91±0.16 8.35±0.30 8.38±1.07 8.51±0.52 BB68 19.78±1.21 13.89±1.02 11.70±1.52 16.45±1.22 BB22 8.45±0.50 9.06±0.38 9.10±0.61 9.12±0.27

[0253] Table 3 Content of vitamin B7 in lactobacillus (Examples 33-89) fermentation supernatant (μg / L)

[0254]

[0255]

[0256] As can be seen from Table 2, when the probiotics in the synbiotic composition are bifidobacteria, a composition of glucose and Bifidobacterium longum subspecies longum W68 (Example 25) can obtain a higher vitamin B7 yield (19.78 μg / L).

[0257] As can be seen from Table 3, when the probiotics in the synbiotic composition are lactobacilli, a composition of isomaltooligosaccharide and Lactobacillus acidophilus LA-5 (Example 56) can obtain a higher microbial B7 yield (10.67 μg / L).

[0258] The embodiments of the present invention are described in detail above, but the present invention is not limited to the above embodiments. Various changes can be made within the knowledge of ordinary technicians in the relevant technical field without departing from the purpose of the present invention. In addition, the embodiments of the present invention and the features in the embodiments can be combined with each other without conflict.

Claims

1. A method for promoting probiotic fermentation to synthesize vitamin B7, characterized in that: The method comprises the following steps: transferring the Lactobacillus acidophilus LA-5 bacterial liquid into a fresh MRSc liquid culture medium at a 1% inoculation amount, culturing at 37°C for 24 hours, and then transferring to a MRSc culture medium with oligomaltose as a carbon source, culturing at 37°C for 24 hours to obtain a fermentation culture containing vitamin B7; The preparation method of the MRSc culture medium comprises: weighing 10 g of beef extract powder, 10 g of tryptone, 5 g of yeast extract powder, 2 g of dipotassium hydrogen phosphate, 2 g of triammonium citrate, 0.5 g of magnesium sulfate heptahydrate, 0.25 g of manganese sulfate tetrahydrate, 5 g of sodium acetate, 1 mL of Tween-80 and 0.5 g of cysteine ​​hydrochloride, dissolving them in 980 mL of distilled water, fixing the volume to 1 L, sterilizing at 121° C. for 15 min, and cooling to obtain the culture medium; The added amount of isomaltooligosaccharide is 20 g / L.

2. A fermented culture of probiotics, characterized in that: The fermentation culture is prepared by the method according to claim 1.

3. A food, characterized in that: The food product comprises the fermentation culture according to claim 2.

4. The food according to claim 3, characterized in that The food comprises at least one of dairy products, cereal products, bean products, condiments and beverages.